AZ and CRUK team up to go all-in on CRISPRAstraZeneca and Cancer Research UK are collaborating to launch a centre of excellence in genetic screening, cancer modelling Share XAZ and CRUK team up to go all-in on CRISPRhttps://pharmaphorum.com/news/az-cruk-crispr/
New AI tech could outperform humans in medical imagingTech firm Cambridge Consultants has announced a new Artificial Intelligence (AI) technology that can produce more accurate medical Share XNew AI tech could outperform humans in medical imaginghttps://pharmaphorum.com/news/new-ai-tech-could-outperform-humans-in-medical-imaging/
Digital health market to top $379bn by 2024The digital health market is set to exceed $379 billion by 2024, according to a new report by Share XDigital health market to top $379bn by 2024https://pharmaphorum.com/news/digital-health-market-to-top-379bn-by-2024/
Beckley Canopy Therapeutics raises £7.4m for cannabis R&DOxford-based biopharma Beckley Canopy Therapeutics has raised £7.4 million to develop a range of cannabis-based products for the Share XBeckley Canopy Therapeutics raises £7.4m for cannabis R&Dhttps://pharmaphorum.com/news/beckley-canopy-therapeutics-raises-7-4m-for-cannabis-rd/
GSK enters PARP space with TESARO acquisitionGSK has announced that it will acquire US-based oncology specialist TESARO for $5.1 billion, gaining access to its Share XGSK enters PARP space with TESARO acquisitionhttps://pharmaphorum.com/news/gsk-enters-parp-space-with-tesaro-acquisition/
P&G completes acquisition of Merck KGaA’s OTC divisionProcter & Gamble (P&G) has completed its acquisition of Merck KGaA’s Consumer Health business, in a move it Share XP&G completes acquisition of Merck KGaA’s OTC divisionhttps://pharmaphorum.com/news/pg-completes-acquisition-merck-kgaas-otc-division/
